Inovio Pharmaceuticals raised to buy from neutral by H.C. Wainwright
INO•H.C. Wainwright raised its rating on Inovio Pharmaceuticals to buy from neutral.
Related News
River City Bank: Stephens raises target price to $61 from $55
RCBC•
Entergy Q3 profit beats estimates on retail sales; raises dividend
ETR•
Global economy: Manufacturing solid but strain of energy costs, supply disruptions starts to show
SPY•
Ryanair CEO expects to hedge 50% of next year's fuel, willing to take risk on remainder
RYAAY•
Mizuho raises Axis Capital Holdings' target price to $123 from $116
AXS•